AXIOS October 19, 2023
Maya Goldman

A Medicare proposal to help alleviate major shortages of cancer drugs and other essential medicines could disadvantage facilities serving vulnerable populations and instigate new supply issues, experts and hospital groups say.

Why it matters: Over 300 drugs have been in shortage this year, nearly the highest amount in a decade, and many health care providers report having to ration drugs or medical equipment in short supply. Despite heightened attention on the issue in Washington, there are few easy fixes.

Driving the news: The Centers for Medicare and Medicaid Services is considering reimbursing hospitals for some of the cost of creating and keeping a three-month stockpile of up to 86 critical medicines.

  • The initiative comes in response to a slew...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Pharma, Pharma / Biotech, Provider
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article